A phase III, randomised, open-label, comparative safety and efficacy trial of intravenous iron isomaltoside (Monofer®) and iron sucrose (Venofer) in subjects with iron deficiency anaemia and non-dialysis-dependent chronic kidney disease - Regional Cancer Care Associates LLC

Clinical Trials

A phase III, randomised, open-label, comparative safety and efficacy trial of intravenous iron isomaltoside (Monofer®) and iron sucrose (Venofer) in subjects with iron deficiency anaemia and non-dialysis-dependent chronic kidney disease

Type of Cancer
Renal Cancer
Locations
Bethesda
Sponsor
Protocol Number
P-MONOFER-CKD-04
Cancer Diagnosis
To Learn More Call
201-510-0910